Hansoh Pharmaceutical Group (3692.HK) Earnings Analysis

Hansoh Pharmaceutical Group (3692.HK) next reports earnings on 2026-08-20, consensus EPS 0.566 HKD. Last quarter (2026-03-29) it beat with EPS 0.4479 HKD vs 0.3807 HKD est (+17.7%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 30.23.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 3692.HK next report earnings?

Next earnings date2026-08-20
Consensus EPS estimate0.566 HKD
Revenue estimate9.02B

3692.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-290.4479 HKD0.3807 HKD+17.7%Beat
2025-08-180.577 HKD0.3922 HKD+47.1%Beat
2025-03-240.2981 HKD0.2449 HKD+21.7%Beat

Beat rate: 3/3 (100%) over reported quarters with consensus data.

3692.HK valuation and analyst view

Trailing P/E30.23
Trailing EPS0.92524 HKD
Price / book4.77
Dividend yield1.32%
Market cap199.23B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Hansoh Pharmaceutical Group (3692.HK)'s next earnings date?

Hansoh Pharmaceutical Group is next scheduled to report on 2026-08-20, with a consensus EPS estimate of 0.566 HKD and revenue estimate of 9.02B.

Did 3692.HK beat earnings last quarter?

In its 2026-03-29 report, 3692.HK posted EPS of 0.4479 HKD versus a 0.3807 HKD estimate — a beat of 17.7%.

What is 3692.HK's earnings track record?

Over the last 3 reported quarters with consensus data, 3692.HK beat estimates 3 times (100%).

What is 3692.HK's current P/E ratio and EPS?

3692.HK trades at a trailing P/E of 30.23 on trailing EPS of 0.9252445759433892 HKD.

What do analysts rate 3692.HK?

3692.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.